Indian Government ab homoeopathic factories ke liye specialized inspectors compulsory kar rahi hai. Ayush sector mein quality control badhane ke liye ye ek bada kadam hai, lekin chhote players par compliance ka load badh sakta hai.
Regulatory Badlav Ka Asar
Government ab Drugs and Cosmetics Rules, 1945 ke Rule 49 ko change karne ki taiyari mein hai. Ab tak aisa koi rule nahi tha, par ab homoeopathic manufacturing units ko audit karne wale inspectors ke paas specific homoeopathic ya pharmacy ki degree hona zaroori hoga. Ye recommendation Drugs Controller General of India ki committee ne di hai taaki modern manufacturing processes ko better monitor kiya ja sake.
Ayush Sector Ka Future
Poora Ayush sector, jisme Ayurveda aur Homoeopathy jaise streams aate hain, aaj $36.92 Billion ka market hai aur $1.25 Billion ka export karte hain. Government ka maqsad hai 'One Herb, One Standard' ke zariye quality harmonize karna.
Investors Ke Liye Kya Hai?
Ye news ek double-edged sword hai:
- Positive Side: Jo badi companies pehle se hi high quality maintain kar rahi hain, unke liye ye faydemand hoga. Unka market share badh sakta hai kyunki quality trust badhega.
- Risk Factor: Chhote manufacturers ke liye mushkil badh sakti hai. Infrastructure aur documentation upgrade karne mein cost zyada aayegi, jisse unke profit margins par pressure pad sakta hai. Agar ye units naye standards meet nahi kar paayi, toh licence cancellation tak ki naubat aa sakti hai.
Investors ko ab ye dekhna chahiye ki kaunsi companies is naye compliance ko jaldi adopt karti hain aur kaunsi peeche reh jaati hain.